In CRC, this rate is even as high as 60–70% [51], in which 20–30% is attributable to the PIK3CA mutation, which codes for the mutated active form of class IA PI3K catalytic subunit p110α. This evidence concerns the gene PIK3CA and colorectal carcinoma.